“Most common TB test is more than 125 years old; TB drugs are more than 40 years old” Microsoft chairman and philanthropist Bill Gates on Thursday said the large number of deaths in the world due to tuberculosis was unacceptable and the Bill and Melinda Gates Foundation was all for supporting a low-cost affordable vaccine for the disease. “Whatever helps the poorest, we are committed to it,'' Mr. Gates said at...
More »SEARCH RESULT
Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar
As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB DR-TB medicines are very expensive Need to improve access to DR-TB drugs As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international...
More »TB still cause for concern in South East Asia: WHO
World Tuberculosis Day to be observed today 2 million people successfully treated annually through DOTS Tuberculosis (TB) remains one of the biggest threats to public health in the World Health Organisation (WHO) - South-East Asia Region, causing one death a minute. Although the total number of people affected by the disease has steadily declined in the last decade, there are five million people living with TB in the region — a third...
More »Antibiotic challenges, dilemmas, policies by KS Jacob
India faces the challenge of inappropriate use of antibiotics while Bharat copes with poor access to treatment, resulting in a policy conundrum and inaction. India was recently in the news for the wrong reasons. The serious threat posed by the newly discovered microbe, NDM-1 (New Delhi metallo--lactamase-1), resistant to many antibiotics, triggered alarm and panic. Predictions that the country will not meet the millennium development goal for child mortality caused dismay....
More »Naming superbug after Delhi an ‘error’, Lancet says sorry by Teena Thacker
The editor of The Lancet, Richard Horton, has said naming a superbug after New Delhi was an “error”, and has apologised. Some Europeans returning from South Asia had been found infected with a bacteria carrying a drug-resistant gene last year, which had been named New Delhi metallo-beta-lactamase, or NDM-1, as the first patient had flown from Delhi to Sweden with the infection. While acknowledging this was a mistake, Horton said, “the science...
More »